Board of Directors

Stan Polovets – Chairman of the Board

Mr. Polovets joined the board of Anchiano in April 2020. A graduate of Stanford Graduate School of Business, he also currently serves as a member of the Board of Overseers of New York University (NYU) Tandon School of Engineering, NYU President’s Global Council, and the Council on Foreign Relations.

Mr. Polovets previously served as CEO of AAR, a private equity firm with a global energy portfolio valued in excess of $25 billion, and as Sr. Vice President at TNK-BP, one of the world’s largest oil companies. Mr. Polovets also held management, advisory, M&A and various financial positions at ExxonMobil, KPMG, TNK-BP and EY.

Mr. Polovets brings extensive board experience to Anchiano. Prior to joining its board, Mr. Polovets served as Lead Non-Executive Director of Clal Industries, Lead Independent Director of L1 Energy, Lead Independent Director at Taavura, member of the Board of Overseers at Stanford University’s Hoover Institution, Chairman for Eastern Europe at Edelman, and director at oil companies Slavneft and TNK-BP.

He is a co-founder and chairman of The Genesis Prize Foundation, a prominent international philanthropic group.


Ruth (Ruti) Alon

Ms. Alon is the founder and CEO of Medstrada Israel. Between 1997 and 2016, Ms. Alon served as a General Partner of Pitango Venture Capital. Prior to her tenure at Pitango, Ms. Alon held senior positions with Montgomery Securities from 1981 to 1987, Genesis Securities, LLC from 1993 to 1996, and Kidder Peabody & Co. from 1987 to 1993, as well as managing her own medical device independent consulting business in San Francisco from 1995 to 1996. Ms. Alon was the Founder and Chairperson of Israel Life Science Industry, a not-for-profit organization then representing the mutual goals of approximately 700 Israeli life science companies. She is also the Co-Founder of IATI, Israel Advanced Technology Industries, an umbrella organization for all high-tech and life sciences companies in Israel. She has a B.A. in Economics from the Hebrew University of Jerusalem, Israel and an M.B.A. from Boston University.


Neil Cohen

Mr. Cohen has served as the Chairman and Chief Executive Officer of Castel Partners Ltd. since January 2012. In 1994 he co-founded Israel Seed Partners, a leading venture capital firm, and managed the firm until 2019. Mr. Cohen has invested in and served on the boards of directors of many private technology companies, including a large number which were acquired or completed successful initial public offerings, including Compugen (Nasdaq: CGEN), (Nasdaq: SHOP, acquired by EBAY), Broadlight (acquired by Broadcom, Nasdaq: AVGO) and Cyota (acquired by RSA). He is a venture partner at SKY, an Israeli middle-market private equity firm, at Hetz Ventures Management Ltd., an early-stage Israeli venture capital fund, and Shavit Capital. Mr. Cohen was previously the Business Editor of The Jerusalem Post and began his career in the private equity group at N M Rothschild & Sons Limited in London. Mr. Cohen received a B.A. and M.A., with first class honors, from Oxford University. 


Isaac Kohlberg

Mr. Kohlberg has served as a director since February 2017. He is the Senior Associate Provost and Chief Technology Development Officer of Harvard University. Previously, he was CEO of the Tel Aviv University Economic Corporation and CEO of RAMOT at Tel Aviv University. He served as Vice President at New York University Medical Center and Vice Provost of New York University. He also served as the Managing Director of Yeda R&D Company of the Weizmann Institute of Science.

Mr. Kohlberg received his M.B.A. from INSEAD and LL.B. from Tel Aviv University.